O-tert-Butyl-L-threonine
CAS: 4378-13-6
Ref. 3D-FB46966
2g | Discontinued | ||
5g | Discontinued | ||
10g | Discontinued | ||
25g | Discontinued | ||
50g | Discontinued |
Product Information
- L-Thr(tBu)-OH
- (2S,3R)-2-ammonio-3-tert-butoxybutanoate
- <span class="text-smallcaps">L</span>-Threonine, O-(1,1-dimethylethyl)-
- Butyric acid, 2-amino-3-tert-butoxy-, <span class="text-smallcaps">L</span>-
- H-Thr(But)-OH
- H-Thr(tBu)-OH
- O-(1,1-Dimethylethyl)-<span class="text-smallcaps">L</span>-threonine
- O-T-butyl-L-threonine
- O-tert-Butyl-<span class="text-smallcaps">L</span>-threonine
- Threonine tert-butyl ether
- See more synonyms
- Butyric acid, 2-amino-3-tert-butoxy-, L-
- O-(1,1-Dimethylethyl)-L-threonine
- L-Threonine, O-(1,1-dimethylethyl)-
O-tert-Butyl-L-threonine is a synthetic amino acid that has been shown to inhibit the growth of cancer cells. It has also been shown to have low toxicity in rats and mice, which makes it an excellent candidate for use as a positron emission tomography (PET) tracer. O-tert-Butyl-L-threonine is converted into L-threonine by enzymatic hydrolysis and then enters the bloodstream, where it can be detected using PET scans. This drug is also able to target tumors with high levels of galacturonic acid and pegylated with polyethylene glycol to increase its half life in the body, making it an attractive option for pharmacokinetic studies. O-tert-Butyl-L-threonine has also shown antibacterial activity against methicillin resistant Staphylococcus aureus and Enterococcus faecalis strains.